AC Immune
ACIU
50 hedge funds and large institutions have $139M invested in AC Immune in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 11 closing their positions.
27% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 11
4% more funds holding
Funds holding: 48 → 50 (+2)
1.59% more ownership
Funds ownership: 28.26% → 29.86% (+1.6%)
14% less capital invested
Capital invested by funds: $163M → $139M (-$23.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
55% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.72M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.33M |
| 3 |
Renaissance Technologies
New York
|
+$1.48M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.45M |
| 5 |
QI
QS Investors
New York
|
+$966K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Prosight Management
Dallas,
Texas
|
-$1.44M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$485K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$369K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$307K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$287K |
ACIU Hedge Fund Activity: Q1 2020 in Review
50 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q1 2020, worth a combined $139M — down 14% from $163M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ACIU positions and 11 closed out — a net gain of 3 holders — while 9 added to existing stakes and 20 trimmed.
The largest buyer was Millennium Management, adding an estimated $3.72M. The largest seller was Prosight Management, cutting an estimated $1.44M.
- 50 institutional investors held AC Immune (ACIU) as of Q1 2020, up from 48 in Q4 2019.
- Funds reported $139M of AC Immune stock for Q1 2020, down 14% quarter-over-quarter.
- 14 funds opened new AC Immune positions in Q1 2020 and 11 closed out, a net change of +3 holders.
- The largest AC Immune buyer in Q1 2020 was Millennium Management, an estimated $3.72M added.
- The largest AC Immune seller in Q1 2020 was Prosight Management, an estimated $1.44M sold.
Based on aggregated 13F filings for Q1 2020.